Detalhe da pesquisa
1.
Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.
Med Sci Monit;
24: 2317-2329, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29664897
2.
Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study.
Front Immunol;
14: 1136169, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36969249
3.
The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R.
Cancer Manag Res;
10: 4125-4134, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30323668
4.
Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.
Oncotarget;
9(3): 3230-3241, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29423042
5.
Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis
Asian Pac J Cancer Prev;
19(5): 1397-1404, 2018 May 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29802706
6.
Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.
Cancer Med;
7(9): 4755-4764, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30105829
7.
Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma.
Sci Rep;
7: 41449, 2017 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28150694